Discovery of somatic ERBB2 mutations in human gallbladder cancer

被引：0
|
作者：
Iyer, P. [1 ]
Gardi, N. [1 ]
Ranjan, M. [1 ]
Chandrani, P. [1 ]
Upadhyay, P. [1 ]
Ramadwar, M. R. [2 ]
Shrikhande, S. V. [3 ]
Dutt, A. [1 ]
机构：
[1] Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumbai, India
[2] Tata Mem Hosp, Dept Pathol, Bombay, Maharashtra, India
[3] Tata Mem Hosp, Dept Gastrointestinal & Hepatopancreatobiliary Su, Bombay, Maharashtra, India
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P48-K002
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] Landscape of somatic ERBB2 Mutations: Findings from AACR GENIE and comparison to ongoing ERBB2 mutant basket study
    Schram, Alison
    Won, Helen H.
    Andre, Fabrice
    Arnedos, Monica
    Meric-Bernstam, Funda
    Bedard, Philippe L.
    Shaw, Kenna R.
    Horlings, Hugo
    Micheel, Christine
    Park, Ben Ho
    Mann, Grace
    Lalani, Alshad S.
    Smyth, Lillian
    Solit, David B.
    Schrag, Deborah
    Levy, Mia A.
    Rollins, Barrett J.
    Routbort, Mark
    Sawyers, Charles L.
    Lepisto, Eva
    Berger, Michael F.
    Hyman, David M.
    CANCER RESEARCH, 2017, 77
  • [2] Extracellular domain ERBB2 (ERBB2 ECD+) mutations in urothelial bladder cancer (UBC).
    Basin, Michael
    Jacob, Joseph M.
    Bratslavsky, Gennady
    Grivas, Petros
    Spiess, Philippe E.
    Li, Roger
    Necchi, Andrea
    Pavlick, Dean C.
    Huang, Richard S. P.
    Lin, Douglas I.
    Danziger, Natalie
    Sokol, Ethan
    Sivakumar, Smruthy
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [3] Oncogenic extracellular domain mutations of ERBB2 in cancer
    Greulich, Heidi
    Kaplan, Bethany
    Mertins, Philipp
    Chen, Tzu-Hsiu
    Tanaka, Kumiko
    Yun, Cai-Hong
    Imielinski, Marcin
    Banerji, Shanatanu
    Lawrence, Michael S.
    Walker, Sarah
    Winckler, Wendy
    Getz, Gad
    Frank, David
    Eck, Michael
    Jaffe, Jacob D.
    Carr, Steven A.
    Wong, Kwok-Kin
    Meyerson, Matthew
    CANCER RESEARCH, 2012, 72
  • [4] Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinoma
    Wong, Chiung-Ing
    Yap, Hui-Ling
    Lim, Seng-Gee
    Guo, Jia-Yi
    Goh, Boon-Cher
    Lee, Soo-Chin
    HEPATOLOGY RESEARCH, 2008, 38 (08) : 838 - 841
  • [5] Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas
    Lee, JW
    Soung, YH
    Seo, SH
    Kim, SY
    Park, CH
    Wang, YP
    Park, K
    Nam, SW
    Park, WS
    Kim, SH
    Lee, JY
    Yoo, NJ
    Lee, SH
    CLINICAL CANCER RESEARCH, 2006, 12 (01) : 57 - 61
  • [6] ERBB2 kinase mutations in lung-cancer tumours
    Senior, K
    LANCET ONCOLOGY, 2004, 5 (11): : 647 - 647
  • [7] Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2
    Liu, Yuzhi
    Bischof, Evelyne
    Chen, Zhiqin
    Zhou, Jiahuan
    Zhang, Bei
    Zhang, Ding
    Gao, Yong
    Quan, Ming
    ONCOLOGY RESEARCH, 2024, 32 (09) : 1429 - 1438
  • [8] Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients
    Jongen, L.
    Floris, G.
    Lambrechts, D.
    Laenen, A.
    Neven, P.
    Cutler, R. E., Jr.
    Lalani, A. S.
    Wildiers, H.
    CANCER RESEARCH, 2017, 77
  • [9] Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients
    Jongen, Lynn
    Floris, Giuseppe
    Lambrechts, Diether
    Laenen, Annouschka
    Neven, Patrick
    Mann, Grace
    Cutler, Richard E., Jr.
    Lalani, Alshad S.
    Wildiers, Hans
    CANCER RESEARCH, 2018, 78 (04)
  • [10] Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib
    de Martino, Michela
    Zhuang, Dazhong
    Klatte, Tobias
    Rieken, Malte
    Roupret, Morgan
    Xylinas, Evanguelos
    Clozel, Thomas
    Krzywinski, Martin
    Elemento, Olivier
    Shariat, Shahrokh F.
    CANCER BIOLOGY & THERAPY, 2014, 15 (09) : 1239 - 1247
12345